dr. jahanzeb on the future of adjuvant therapy in her2 breast cancer
Published 7 years ago • 94 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:53
dr. jahanzeb discusses advancements in adjuvant her2 breast cancer
-
2:06
dr. jahanzeb on the aphinity and extenet trials in breast cancer
-
1:02
dr. mohammad jahanzeb on neratinib and trastuzumab in her2-positive breast cancer
-
1:29
dr. ali on the future of adjuvant care for her2 breast cancer
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
2:09
adjuvant therapy data for her2-positive breast cancer
-
1:19
dr. jahanzeb on the benefit of pertuzumab plus trastuzumab in her2 breast cancer
-
1:52
tils as a prognostic biomarker for treatment de-escalation in her2-positive breast cancer
-
2:35
dr. jahanzeb on overcoming her2 resistance in breast cancer
-
3:48
making sense of adjuvant therapy in her2 breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
2:18
dr. hershman on the use of endocrine therapy in premenopausal hr /her2- breast cancer
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
1:46
dr. esteva discusses adjuvant trastuzumab in her2 breast cancer
-
1:09
dr. mortimer on adjuvant therapy in early-stage her2 breast cancer
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
3:58
future directions in the adjuvant treatment of her2 breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer